The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. (Q53242907)

12 May 2018

title

The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. (English)

1 reference

12 May 2018

author

Andrea Pellagatti

5

1 reference

12 May 2018

Mirella Meregalli

object named as

M Meregalli

4

0 references

author name string

M Sampietro

1

1 reference

12 May 2018

L Caputo

2

1 reference

12 May 2018

A Casatta

3

1 reference

12 May 2018

J Tagliabue

6

1 reference

12 May 2018

G Annoni

7

1 reference

12 May 2018

C Vergani

8

1 reference

12 May 2018

publication date

1 July 2001

1 reference

12 May 2018

published in

Neurobiology of Aging

1 reference

12 May 2018

volume

22

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

563-568

1 reference

12 May 2018

HLA A2 allele is associated with age at onset of Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Clinical and biochemical abnormalities in people heterozygous for hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Brain samples from Alzheimer's patients have elevated levels of loosely bound iron.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Global prevalence of putative haemochromatosis mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Are hereditary hemochromatosis mutations involved in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Association of transferrin C2 allele with late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

The role of iron in beta amyloid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Free radical damage, iron, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

Transferrin C2, metal binding and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900219-6

7 January 2021

10.1016/S0197-4580(01)00219-6

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

11445256

1 reference

12 May 2018